Annovis Bio (ANVS) Short Interest Ratio & Short Volume → CEO of Biggest AI Chipmaker Just Dropped a Bombshell… (From Banyan Hill Publishing) (Ad) Free ANVS Stock Alerts $8.31 +0.28 (+3.49%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Annovis Bio Short Interest DataCurrent Short Volume1,610,000 sharesPrevious Short Volume1,450,000 sharesChange Vs. Previous Month+11.03%Dollar Volume Sold Short$8.89 millionShort Interest Ratio / Days to Cover3.6Last Record DateApril 30, 2024Outstanding Shares11,170,000 sharesPercentage of Shares Shorted14.41%Today's Trading Volume472,061 sharesAverage Trading Volume1,172,607 sharesToday's Volume Vs. Average40% Short Selling Annovis Bio ? Sign up to receive the latest short interest report for Annovis Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatANVS Short Interest Over TimeANVS Days to Cover Over TimeANVS Percentage of Float Shorted Over Time Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. Annovis Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,610,000 shares $8.89 million +11.0%N/A3.6 $5.52 4/15/20241,450,000 shares $16.11 million -3.3%N/A5.9 $11.11 3/31/20241,500,000 shares $17.85 million +11.1%N/A5.6 $11.90 3/15/20241,350,000 shares $12.30 million -8.2%17.3%4.2 $9.11 2/29/20241,470,000 shares $12.45 million +7.3%19.1%5 $8.47 2/15/20241,370,000 shares $15.43 million +4.6%18.0%4.2 $11.26 Get the Latest News and Ratings for ANVS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Annovis Bio and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,310,000 shares $14.45 million +33.7%17.2%4.3 $11.03 1/15/2024980,200 shares $12.59 million +1.7%13.3%3.7 $12.84 12/31/2023963,800 shares $18.02 million +51.6%13.0%4 $18.70 12/15/2023635,600 shares $6.93 million +21.2%8.6%3.5 $10.90 11/30/2023524,500 shares $4.45 million +8.9%7.5%4 $8.49 11/15/2023481,700 shares $2.88 million -7.7%6.9%6.2 $5.97 10/31/2023521,700 shares $3.42 million +23.3%7.2%9.7 $6.56 10/15/2023423,300 shares $3.33 million +25.4%6.7%10.4 $7.86 9/30/2023337,600 shares $3.20 million -8.6%5.3%12.2 $9.49 9/15/2023369,200 shares $3.91 million +6.1%5.8%12.9 $10.60 8/31/2023348,000 shares $4.32 million -5.3%5.5%14.3 $12.40 8/15/2023367,500 shares $4.72 million -2.1%5.8%13.3 $12.83 7/31/2023375,400 shares $5.18 million -9.4%5.9%12.8 $13.79 7/15/2023414,300 shares $5.73 million +1.9%6.5%12.7 $13.82 6/30/2023406,600 shares $5.79 million -5.8%6.4%9.6 $14.25 6/15/2023431,800 shares $6.36 million +11.1%6.8%5.2 $14.74 5/31/2023388,800 shares $5.09 million -1.2%6.4%4.5 $13.10 5/15/2023393,700 shares $5.45 million -20.8%6.5%4.7 $13.85 4/30/2023496,900 shares $7.24 million +6.7%8.2%5.6 $14.57 4/15/2023465,700 shares $7.00 million +30.1%8.4%4.5 $15.03 3/31/2023357,900 shares $5.52 million +39.6%6.4%3.7 $15.41 3/15/2023256,400 shares $4.06 million +2.9%4.6%4.6 $15.84 2/28/2023249,200 shares $4.26 million +6.6%4.5%4.7 $17.11 2/15/2023233,800 shares $4.03 million +22.4%4.2%4.5 $17.22 1/31/2023191,000 shares $3.16 million -1.6%3.4%4.1 $16.52 1/15/2023194,100 shares $2.49 million -2.1%3.4%6.8 $12.81 12/30/2022198,300 shares $2.66 million +21.9%3.5%6.3 $13.43 12/15/2022162,700 shares $1.98 million -4.4%2.9%3.9 $12.16 11/30/2022170,100 shares $2.29 million +7.7%3.0%2.3 $13.44 11/15/2022158,000 shares $2.14 million -11.2%2.8%2.1 $13.55 10/31/2022178,000 shares $2.23 million -9.6%3.2%2.3 $12.55 10/15/2022197,000 shares $2.46 million +13.0%3.5%2.5 $12.50 9/30/2022174,400 shares $2.39 million -22.7%3.1%2 $13.70 9/15/2022225,700 shares $4.92 million +47.5%4.0%2.1 $21.81The ONE AI Stock to own now. (It’s not Nvidia.) (Ad)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. ANVS Short Interest - Frequently Asked Questions What is Annovis Bio's current short interest? Short interest is the volume of Annovis Bio shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 1,610,000 shares of ANVS short. Learn More on Annovis Bio's current short interest. What is a good short interest ratio for Annovis Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANVS shares currently have a short interest ratio of 4.0. Learn More on Annovis Bio's short interest ratio. Which institutional investors are shorting Annovis Bio? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Annovis Bio: Ikarian Capital LLC, Affinity Asset Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Annovis Bio's short interest increasing or decreasing? Annovis Bio saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 1,610,000 shares, an increase of 11.0% from the previous total of 1,450,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Annovis Bio's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Annovis Bio: ProPhase Labs, Inc. (1.88%), Milestone Pharmaceuticals Inc. (0.81%), YS Biopharma Co., Ltd. (0.32%), Barinthus Biotherapeutics plc (0.05%), Eton Pharmaceuticals, Inc. (0.36%), Chimerix, Inc. (1.71%), LifeVantage Co. (0.78%), Oncolytics Biotech Inc. (1.14%), IO Biotech, Inc. (0.10%), Anixa Biosciences, Inc. (2.08%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Annovis Bio stock? Short selling ANVS is an investing strategy that aims to generate trading profit from Annovis Bio as its price is falling. ANVS shares are trading up $0.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Annovis Bio? A short squeeze for Annovis Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANVS, which in turn drives the price of the stock up even further. How often is Annovis Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANVS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: ProPhase Labs Short Squeeze Milestone Pharmaceuticals Short Squeeze YS Biopharma Short Squeeze Barinthus Biotherapeutics Short Squeeze Eton Pharmaceuticals Short Squeeze Chimerix Short Squeeze LifeVantage Short Squeeze Oncolytics Biotech Short Squeeze IO Biotech Short Squeeze Anixa Biosciences Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:ANVS) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits